| FDA sets date to review Affymax anemia drug - BusinessWeek |
|
|
BusinessWeek Affymax is seeking approval to market the drug to adult patients on kidney dialysis, who typically suffer from anemia, a blood disorder that causes dizziness and weakness. Peginesatide is part of a class of drugs known as erythropoiesis stimulating |